Search…
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Search...
TOP News
Latest
Recommend
HK Stock
US Stock
China Stock
Macro
Bond
Commercial
Global
Investment&Financing
Company&Products
Character
ESG
Economy&politics
Hong Kong
China
America
Stocks
HK Stock
China Stock
US Stock
Markets
HK Stock
US Stock
IPO
Hong Kong
America
China
Research
US Stock
HK Stock
Opinion
Recommendation
Home
>
Latest
Lates News
15/09/2025
Hong Kong stock Medivano-B continues to rise, closing up 117% with current price at 420 Hong Kong dollars per share.
Latest
1 m ago
Kanglong Huacheng: Wholly-owned subsidiary passes on-site inspection by the US FDA.
1 m ago
Kanglong Huacheng announced that its wholly-owned subsidiary Kanglong Huacheng (Shaoxing) Pharmaceutical Co., Ltd. underwent a pre-approval inspection by the U.S. FDA for cGMP from May 29, 2025 to June 4, 2025. The inspection covered various aspects such as quality system, material management system, and production management system. Recently, Kanglong Shaoxing received an on-site inspection report issued by the U.S. FDA, confirming that its production facilities passed the inspection smoothly and complied with U.S. drug cGMP quality standards and obtained certification from the U.S. FDA. This is the first time that the company's Shaoxing active pharmaceutical ingredient commercial production base passed the pre-approval inspection by the U.S. FDA, and it is also the second time that the company's active pharmaceutical ingredient production workshop in China passed the inspection by the U.S. FDA following the inspection in April 2025.
2 m ago
After Tesla's stock price rose by 7.3% the previous trading day, it increased by another 4.2% in pre-market trading.
2 m ago
Tesla's stock price rose by 4.2% in pre-market trading after rising by 7.3% in the previous trading day.
2 m ago
Whirlpool (WHR.US) questions Samsung, LG, and others for underreporting import prices to evade tariffs.
See all latest